Patel Tejal, Slonim Karen, Lee Linda
School of Pharmacy (Patel), University of Waterloo; The Centre for Family Medicine Family Health Team (Patel, Slonim, Lee), Kitchener; and the Department of Family Medicine (Lee), McMaster University, Hamilton, Ontario.
Can Pharm J (Ott). 2017 May 1;150(3):169-183. doi: 10.1177/1715163517701770. eCollection 2017 May-Jun.
Older adults with dementia are at high risk for drug-related adverse outcomes. While much is known about potentially inappropriate medication use in older adults, its prevalence and characteristics among those with dementia are not as well elucidated. We conducted a literature review to examine the prevalence of potentially inappropriate medication use among home-dwelling older adults with dementia. Our secondary aim was to determine the most frequently implicated medications and factors associated with potentially inappropriate medication use.
MEDLINE, EMBASE, CINAHL, and International Pharmaceutical Abstracts were searched between 1946 and 2014 for articles that referenced potentially inappropriate medication use and types of dementia. One reviewer screened all titles and abstracts from the initial search and full-text articles after the initial screen for eligibility, then 2 reviewers independently abstracted data from included studies.
Searches yielded 81 articles, of which 7 met inclusion criteria. Prevalence of potentially inappropriate medication use varied from 15% to 46.8%. No single drug or drug class was reported consistently across all studies as the most frequent potentially inappropriate medication, but anticholinergics and benzodiazepines, drugs that affect cognition, were among the most common medications or pharmacological classes listed.
Older adults with dementia may be particularly vulnerable to potentially inappropriate medications because of cognitive impairment from their condition and the greater likelihood of experiencing adverse events from medications. Given this population's greater susceptibility to adverse events, more intense medication and patient monitoring may be warranted, especially among those taking anticholinergics and benzodiazepines, as these drugs can contribute to cognitive impairment.
患有痴呆症的老年人面临与药物相关不良后果的高风险。虽然对于老年人潜在不适当用药已有很多了解,但痴呆症患者中其患病率和特征尚未得到充分阐明。我们进行了一项文献综述,以研究居家痴呆症老年人中潜在不适当用药的患病率。我们的次要目标是确定最常涉及的药物以及与潜在不适当用药相关的因素。
检索1946年至2014年间的MEDLINE、EMBASE、CINAHL和《国际药学文摘》,查找提及潜在不适当用药和痴呆症类型的文章。一名评审员筛选初始检索的所有标题和摘要以及初筛后符合纳入标准的全文文章,然后两名评审员独立从纳入研究中提取数据。
检索得到81篇文章,其中7篇符合纳入标准。潜在不适当用药的患病率在15%至46.8%之间。在所有研究中,没有单一药物或药物类别被一致报告为最常见的潜在不适当药物,但抗胆碱能药物和苯二氮䓬类药物(影响认知的药物)是列出的最常见药物或药理学类别之一。
患有痴呆症的老年人可能因病情导致的认知障碍以及药物引发不良事件的可能性更大,而特别容易受到潜在不适当药物的影响。鉴于该人群对不良事件的易感性更高,可能需要更严格的药物和患者监测,尤其是在服用抗胆碱能药物和苯二氮䓬类药物的人群中,因为这些药物会导致认知障碍。